| Name | Safeway Pharmacy #0429 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 3380 Lancaster Dr Ne, Salem, Oregon 97305 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (503) 391-6482 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company.
Eleven years ago this month, the scans and exams that hold the most power to spot the early signs of cancer became available for free to many American adults.
Neuroscientists at Technische Universität Dresden discovered a novel, non-invasive imaging-based method to investigate the visual sensory thalamus, an important structure of the human brain and point of origin of visual difficulties in diseases such as dyslexia and glaucoma.
Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to research findings to be presented tomorrow at the IDWeek conference.
The COVID-19 death rate for people with intellectual and developmental disabilities (IDD) is higher than the general population in several states across the U.S., according to a new study published in Disability and Health Journal.
› Verified 8 days ago
| NPI Number | 1306875349 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #0429 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3380 Lancaster Dr Ne, Salem, OR 97305 |
| Phone Number | 503-391-6482 |
News Archive
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company.
Eleven years ago this month, the scans and exams that hold the most power to spot the early signs of cancer became available for free to many American adults.
Neuroscientists at Technische Universität Dresden discovered a novel, non-invasive imaging-based method to investigate the visual sensory thalamus, an important structure of the human brain and point of origin of visual difficulties in diseases such as dyslexia and glaucoma.
Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to research findings to be presented tomorrow at the IDWeek conference.
The COVID-19 death rate for people with intellectual and developmental disabilities (IDD) is higher than the general population in several states across the U.S., according to a new study published in Disability and Health Journal.
› Verified 8 days ago
News Archive
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company.
Eleven years ago this month, the scans and exams that hold the most power to spot the early signs of cancer became available for free to many American adults.
Neuroscientists at Technische Universität Dresden discovered a novel, non-invasive imaging-based method to investigate the visual sensory thalamus, an important structure of the human brain and point of origin of visual difficulties in diseases such as dyslexia and glaucoma.
Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to research findings to be presented tomorrow at the IDWeek conference.
The COVID-19 death rate for people with intellectual and developmental disabilities (IDD) is higher than the general population in several states across the U.S., according to a new study published in Disability and Health Journal.
› Verified 8 days ago
A Step Forward Llc Type: Prosthetic/Orthotic Supplier Location: 744 Hawthorne Ave Ne, Salem, Oregon 97301 Phone: (503) 798-4988 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2050 Vista Seave 100-110, Salem, Oregon 97302 Phone: (503) 480-1100 | |
Pacific Pulmonary Services Type: DME Supplier - Oxygen Equipment & Supplies Location: 1995 16th St Ne, Salem, Oregon 97301 Phone: (503) 364-0107 | |
Cascade Sleep Supply, Llc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1500 Liberty St Se, Salem, Oregon 97302 Phone: (503) 584-1961 | |
Edm Enterprises, Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 2859 22nd St Se, Salem, Oregon 97302 Phone: (503) 763-2400 |